Clinical Evaluation for Medical Devices Under EU MDR 2017745


ChangJin

Uploaded on Jan 23, 2026

Category Business

This presentation provides a detailed overview of Clinical Evaluation for medical devices under EU MDR 2017/745. It explains what clinical evaluation is, why it is mandatory for all device classes, and how manufacturers must systematically collect, appraise, and analyze clinical data to demonstrate safety, performance, and clinical benefit. The presentation covers key MDR clinical evaluation components including the Clinical Evaluation Plan (CEP), Clinical Evaluation Report (CER), demonstration of equivalence, literature search protocol and report, and benefit risk assessment in line with General Safety and Performance Requirements (GSPR). It also highlights regulatory expectations for CE marking, technical documentation, and ongoing clinical evaluation throughout the device lifecycle. For expert support in MDR clinical evaluation and CER writing, contact [email protected] or visit www.mavenprofserv.com

Category Business

Comments

                     

Clinical Evaluation for Medical Devices Under EU MDR 2017745

Clinical Evaluation for Medical Devices Under EU MDR 2017/745 www.mavenprofserv.c om What is Clinical Evaluation? • Clinical Evaluation is a systematic and ongoing process • It collects, appraises, and analyzes clinical data related to a medical device • Purpose is to confirm: 1.Safety 2.Performance 3.Clinical benefit • Evaluation is performed according to the manufacturer’s Instructions for Use (IFU) Why is Clinical Evaluation • Mandatory requireImenpt ounrdtear EnUt M?DR 2017/745 • Applies to all classes of medical devices • Supports: 1.CE Marking approval 2.Risk–benefit acceptability 3.Market access in the EU • Demonstrates compliance with General Safety and Performance Requirements (GSPR) SCOPE OF CLINICAL EVALUATION • Evaluation is device-specific and based on: 1.Intended purpose 2.Target patient population 3.Clinical indications • Assessment includes: 1.Benefits vs. risks 2.Nature, probability, duration, and frequency of risks 3.Based on current state of the art and scientific knowledge CLINICAL EVALUATION PLAN (CEP) • Defines how the clinical evaluation will be conducted • Includes: ⚬ Evaluation objectives ⚬ Clinical data sources ⚬ Methods of analysis ⚬ Criteria for data appraisal • Forms the foundation of the Clinical Evaluation process CLINICAL EVALUATION • Core documeRntE dPemOoRnsTtr a(tCinEg:R) ⚬ Safety ⚬ Performance ⚬ Clinical effectiveness • Includes: ⚬ Clinical investigation data (if applicable) ⚬ Scientific literature ⚬ Technical and PMS data • Confirms compliance with MDR clinical evaluation requirements DEMONSTRATION OF EQUIVALENCE • Allows use of clinical data from an equivalent device • Equivalence must be shown in: ⚬ Technical characteristics ⚬ Biological characteristics ⚬ Clinical characteristics • Reduces need for new clinical investigations while maintaining compliance LITERATURE SEARCH PROTOCOL & REPORT • Literature Search Protocol • Defines search strategy, keywords, databases, and inclusion criteria • Literature Search Report • Summarizes safety and performance evidence • Documents evaluator conclusions • Supports clinical claims and benefit-risk assessment CLINICAL EVALUATION UNDER MDR • Integral part of 2MD0R1 Te7ch/n7ic4al5 Documentation • Must: ⚬ Provide evidence for relevant GSPRs ⚬ Assess undesirable side effects ⚬ Justify adequacy of clinical evidence • A well-prepared CER ensures: ⚬ Regulatory compliance ⚬ Audit readiness ⚬ Successful CE Marking CONTACT +9U1S- ENQUIRY@MA7V4E9N0P0R1O7F7S7E WWW.RMVA.CVOEMNP4ROFSE RV.COM